arrow
S

Shelly J. Krebs

walter reed army institute of research
H指数:35
被引数:3,764

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Targeting the Zika virus envelope domains I and III as a recombinant vaccine protects mice from lethal challenge

靶向寨卡病毒包膜结构域I和III的重组疫苗保护小鼠免受致死性攻击

2026-04-140
OAAI
Informing the Value of “Boosting” Immunocompetent Adults based on Immune Responses among U.S. Service Members to SARS-CoV-2 Variants in Late 2024

基于2024年末美国服役人员对SARS-CoV-2变种免疫反应,阐明“加强”(Boosting)免疫健全成年人的价值

2026-03-110
OA
Inside out: TNFa-RII and sexualized drug use in acute HIV predicts persistent depressive symptoms despite antiretroviral therapy

从内到外:TNFa-RII和性化药物使用在急性HIV中预示着抗逆转录病毒治疗下的持续性抑郁症状

2025-07-280
OAAI
Single-cell analyses identify monocyte gene expression profiles that influence HIV-1 reservoir size in acutely treated cohorts

单细胞分析确定了急性治疗队列中影响HIV-1储库大小的单核细胞基因表达谱。

2025-05-290
OAAI
CD16 and CD57 expressing gamma delta T cells in acute HIV-1 infection are associated with the development of neutralization breadth
2025-01-311
OAAI
Mosaic vaccine-induced antibody-dependent cellular phagocytosis associated with delayed HIV-1 viral load rebound post treatment interruption
2024-06-010
OAAI
Contemporary HIV-1 consensus Env with AI-assisted redesigned hypervariable loops promote antibody binding
2024-05-090
OAAI
Protective efficacy of a Zika purified inactivated virus vaccine candidate during pregnancy in marmosets
2024-02-176
OAAI
Zika purified inactivated virus (ZPIV) vaccine reduced vertical transmission in pregnant immunocompetent mice
2024-02-153
OAAI
Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques
2024-01-033
OAAI
Evolution of HIV-1 envelope towards reduced neutralization sensitivity, as demonstrated by contemporary HIV-1 subtype B from the United States
2023-12-063
OAAI
Priming with Japanese encephalitis virus or yellow fever virus vaccination led to the recognition of multiple flaviviruses without boosting antibody responses induced by an inactivated Zika virus vaccine
2023-11-010
OAAI
Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo- controlled clinical trial
2023-10-016
OAAI
Distinct mucosal and systemic immunological characteristics in transgender women potentially relating to HIV acquisition
2023-08-221
OA